2
Sept 21 (Reuters) – Paradigm Biopharmaceuticals Ltd : * TRADING HALT PENDING INTERIM ANALYSIS RESULTS FOR PHASE 3 CLINICAL TRIAL Further company coverage:
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
